Evolving treatment strategies in CML - moving from early and deep molecular responses to TKI discontinuation and treatment-free remission: is there a need for longer-term trial outcomes?

Copy For Citation

Eskazan A. E.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, vol.84, no.8, pp.1635-1638, 2018 (SCI-Expanded)

• Publication Type: Article / Editorial Material
• Volume: 84 Issue: 8
• Publication Date: 2018
• Doi Number: 10.1111/bcp.13637
• Journal Name: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.1635-1638
• Istanbul University Affiliated: Yes